Our observations suggested that aberrant elevation of Nrf2 expression occurs in UTUC, and that constitutive activation of this transcription factor is associated with progression of the tumor, biological aggressiveness, and a worse prognosis. This evidence concerns the gene NFE2L2 and renal pelvis/ureter urothelial carcinoma.